EA-5225

EA-5225
	Skeletal formula of EA-5225
Clinical data
ATC code	none;
Identifiers
	IUPAC name 8-[3-(cyclopropylcarbonyl)propyl]-3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5.1]-decane;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C21H29N3O2
Molar mass	355.482 g·mol−1
	InChI InChI=1/C21H29N3O2/c1-22-16-24(18-6-3-2-4-7-18)21(20(22)26)11-14-23(15-12-21)13-5-8-19(25)17-9-10-17/h2-4,6-7,17H,5,8-16H2,1H3;

EA-5225 is a spirocyclic derivative related to butyrophenone. It is based on the series of compounds originating from the laboratories of P. A. J. Janssen. EA-5225 is a skeleton-modified butyrophenone, conferring enhanced biological activity.^[1]

References

This article "EA-5225" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:EA-5225. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

↑ EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

[1] EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

[1]

Clinical data
Skeletal formula of EA-5225
ATC code	none
Identifiers
IUPAC name 8-[3-(cyclopropylcarbonyl)propyl]-3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5.1]-decane
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C₂₁H₂₉N₃O₂
Molar mass	355.482 g·mol⁻¹
InChI InChI=1/C21H29N3O2/c1-22-16-24(18-6-3-2-4-7-18)21(20(22)26)11-14-23(15-12-21)13-5-8-19(25)17-9-10-17/h2-4,6-7,17H,5,8-16H2,1H3

EA-5225

References

📰 Article(s) of the same category(ies)[edit]